Top Markets
Coin of the day
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Rangering i aksjer #17519
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Aksjekurs
$0.8001
Markedsverdi
$235.72M
Endring (1 dag)
-9.07%
Endring (1 år)
-22.32%
Land
US
Handel Invivyd, Inc. (IVVD)

Kategori

Historikk for aksjesplitt for Invivyd, Inc. (IVVD)
Aksjen Invivyd, Inc. (symbol: IVVD) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Sep 02, 2026.
Én IVVD-aksje kjøpt før Sep 02, 2026 tilsvarer i dag 0 IVVD-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH